articleThe LancetJun 1, 2002Closed access

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

JCJean‐Louis ChiassonRGRobert G. JosseRGRamón GomisMHM HanefeldAKAvraham Karasik

Centre Hospitalier de l’Université de Montréal · St. Michael's Hospital · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,545
total citations
FWCI
71.55
Percentile
100%
References
30
Citations per year

Authors

6

Topics & keywords

Topics
Keywords
  • Acarbose
  • Medicine
  • Impaired glucose tolerance
  • Placebo
  • Internal medicine
  • Diabetes mellitus
  • Flatulence
  • Type 2 diabetes
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.